Immunic, Inc.

NASDAQ:IMUX

Biotechnology

Healthcare
$7.39 -0.28%

-$0.04 today

Market cap
$100.83M
Beta
1.39
P/E (TTM)
-4.1
EPS (TTM)
-$3.46
52W Low $5.06High $15.77

Volume 0.39M

Average 0.27M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$103.23M

FY 2025 · Annual

Net Income

-$97.17M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development61.12M71.26M83.22M80.05M81.98M
Selling, General & Admin13.3M15.26M16.01M18.01M21.25M
Operating Expenses91.67M119.49M99.22M98.05M103.23M
Depreciation & Amortization85K77K111K134K168K
EBITDA(92.86M)(86.44M)(93.5M)(100.37M)(97M)
EBITDA Margin—————
Operating Income(91.67M)(119.49M)(99.22M)(98.05M)(103.23M)
Operating Margin—————
Interest Income66K1.04M3.08M3.39M1.04M
Interest Expense01.04M000
Other Income / Expenses(1.28M)(919K)5.61M(2.46M)6.06M
Income Before Tax(92.95M)(120.41M)(93.61M)(100.51M)(97.17M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(92.95M)(120.41M)(93.61M)(100.51M)(97.17M)
Net Margin—————
EPS (Basic)(39.20)(37.80)(21.10)(10.00)(6.24)
EPS (Diluted)(39.20)(37.80)(21.10)(10.00)(6.24)
Weighted Avg Shares2.37M3.18M4.43M10.02M15.57M
Weighted Avg Shares (Diluted)2.37M3.18M4.43M10.02M15.57M

IMUX Earnings Waterfall · TTM

NASDAQ:IMUX · Revenue to Net Income

Key Ratios

EPS$-5.98
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-1.5
P/S Ratio0.0

Analysis

$0 of revenue converted into -$104.3M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-5.98, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 13, 2026
10-QQuarterly reportNov 13, 2026
8-KCurrent reportNov 13, 2026
8-KCurrent reportNov 5, 2026
SC 13G/ASC 13G/A filingNov 2, 2026

How much revenue does IMUX generate?

Immunic, Inc. (IMUX) reported $0.00 of revenue in fiscal 2025.

Is IMUX profitable?

Immunic, Inc. (IMUX) reported -$97.17M of net income.